Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21730097 | 0.81 | CDK9 (0.36) | KDM4ELMNA | |
| SCHEMBL25670673 | 0.78 | POLB (0.30) | — | |
| SCHEMBL18506141 | 0.78 | CYP3A4 (0.34) | — | |
| SCHEMBL19974053 | 0.72 | QRFPR (0.33) | — | |
| SCHEMBL18179620 | 0.71 | — | — | |
| SCHEMBL17466028 | 0.70 | HSD11B1 (0.38) | — | |
| SCHEMBL18498619 | 0.69 | CYP11B1 (0.39) | — | |
| SCHEMBL16064958 | 0.69 | HSD11B1 (0.50) | — | |
| SCHEMBL18173814 | 0.69 | — | — | |
| SCHEMBL19876694 | 0.69 | GRM5 (0.37) | KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512847-B1 | PROCESS FOR THE PREPARATION OF HALOGENATED BICYCLES | BAYER CROPSCIENCE AG (DE) | 2022-03-30 | — | — | EP | disclosed |
| US-20190375766-A1 | PROCESS FOR PREPARING HALOGENATED BICYCLIC SYSTEMS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-12-12 | — | — | US | disclosed |
| EP-3512847-A1 | METHOD FOR PRODUCING HALOGENATED BICYCLIC COMPOUNDS | Bayer CropScience Aktiengesellschaft (DE) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018050515-A1 | METHOD FOR PRODUCING HALOGENATED BICYCLIC COMPOUNDS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190375766-A1 | PROCESS FOR PREPARING HALOGENATED BICYCLIC SYSTEMS | INTS6, POLR2H, NQO2 | KDM4E 1520/4885LMNA 1015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.